“…This model led to the demonstration that breast milk protects against NEC (Barlow et al, 1974;Caplan et al, 1994), and also identified a role for nitric oxide in the pathogenesis of NEC (Nadler et al, 2000), the importance of bacterial colonization and TLR4 activation (Jilling et al, 2006), and the protective effects of beneficial commensal bacteria (Caplan et al, 1999), epidermal growth factor (Dvorak et al, 2002) and HMOs (Jantscher-Krenn et al, 2012). More-recent studies using the rat NEC model have identified mechanisms underlying intestinal barrier dysfunction (Ares et al, 2019), the protective effects of the hormone ghrelin (Meister et al, 2019), thrombomodulin (Li et al, 2019a) and fecal microbiota transplantation (Prado et al, 2019), and the deficiency of intestinal alkaline phosphatase that occurs in experimental NEC (Rentea et al, 2019), a finding that is also seen in human disease (Heath et al, 2019).…”